Phlorizin ameliorates obesity-associated endotoxemia and insulin resistance in high-fat diet-fed mice by targeting the gut microbiota and intestinal barrier integrity

Xiao-Yu Zhang,Jiang Chen,Kang Yi,Ling Peng,Jie Xie,Xun Gou,Tong Peng,Lin Tang

DOI: https://doi.org/10.1080/19490976.2020.1842990

IF: 12.2

2020-11-09

Gut Microbes

Abstract:<span>Phlorizin (PHZ) is one of phytonutrients in apples that contributes to the health-promoting effect implicated by the saying, 'an apple a day keeps the doctor away'. PHZ was firstly identified as a competitive inhibitor of sodium-glucose co-transporters-2 (SGLT2); however, its low bioavailability makes it hard to fully explain its pharmacological mechanisms. This study aimed to investigate the ameliorating effect of PHZ on high-fat diet (HFD)-induced obesity via modulating the "gut microbiota-barrier axis". Firstly, C57BL/6 J mice were fed a normal chow diet (NCD) or HFD coadministered with or without PHZ for 12 weeks. Our results showed that PHZ supplementation significantly reduced HFD-induced body weight gain (<i>P &lt; </i>.001), alleviated metabolic disorders (MDs) like insulin resistance (<i>P &lt; </i>.001) and elevation of serum lipopolysaccharides (LPS) (<i>P &lt; </i>.001), attenuated HFD-induced gut microbiota alterations, enhanced short-chain fatty acids (SCFAs) production (<i>P &lt; </i>.001), and inhibited fecal LPS production (<i>P &lt; </i>.001). To investigate the role of the fecal microbiota in the observed beneficial effects, a fecal microbiota transplantation (FMT) experiment was performed by transplanting the feces of the four groups of mice (as donor mice) daily collected from the fourth week to a new batch of acclimatized HFD-fed mice. Our results confirmed that feeding the gut contents of the PHZ-modulated mice could attenuate HFD-induced MDs, accompanied by enhanced glucagon-like peptide 2 (GLP-2) secretion (<i>P &lt; </i>.001) and restoration of HFD-induced damage in the gut epithelial barrier. This study has provided evidence that the "gut microbiota-barrier axis" was an alternative target for the anti-obesity effect of PHZ. This work has also provided an explanation for the high efficacy of PHZ despite the low bioavailability, and PHZ holds great potential to be developed as a functional food ingredient.</span>

gastroenterology & hepatology,microbiology